Was Alora Pharmaceuticals, LLC hit by ransomware?

Alora Pharmaceuticals, LLC was listed by the morpheus ransomware operation (United States), and stolen data was published on the group's leak site. Darkfield tracks this disclosure with the original leak post, screenshot and group context.

Who is the morpheus ransomware group?

morpheus is a ransomware operator tracked by Darkfield. See the full operator dossier for its known victims, sectors targeted, IOCs and leak-site infrastructure.

What data was leaked in the Alora Pharmaceuticals, LLC breach?

morpheus published data attributed to Alora Pharmaceuticals, LLC. Darkfield captured the leak post and a screenshot of the listing.

Ransomware victim disclosure

← All victims

Alora Pharmaceuticals, LLC

Claimed by Morpheus · listed 1 year ago

$337.4M

Ransom

demanded

15m

Age

since listed · data leaked

Status timeline

ListedApr 1, 2025
Data leakeddate unknown

At a glance

Group: Morpheus
Status: Data leaked
Country: United States
Sector: Healthcare
Listed on leak site: Apr 1, 2025
Ransom demanded: $337.4M

About the victim

AI dossier — public-source company profile

Alora Pharmaceuticals, LLC is a parent holding company operating multiple pharmaceutical and specialty pharmaceutical subsidiaries including Acella Pharma, Avion Rx, Osmotica Pharmaceuticals, Sovpharm, Trigen Lab, and Vertical Pharma. The group operates in the United States pharmaceutical sector with reported annual revenue of $337.4 million.

Industry: Pharmaceuticals & Drug Manufacturing

Attack summary

Severity: high — Confirmed data exfiltration from a multi-subsidiary pharmaceutical company with significant revenue and operational scale. Pharmaceutical sector is regulated and sensitive; subsidiary diversity suggests broad data exposure across multiple business units.

The morpheus group claims to have attacked Alora Pharmaceuticals and its subsidiary companies, exfiltrating data. The group has published data and is demanding a ransom of $337.4 million.

high

Data the group says was taken

AI dossier — extracted from the leak post

Corporate records
Subsidiary operational data
Business documents

What the group claims

**Website**: alorapharma.com acellapharma.com avionrx.com osmotica.com sovpharm.com trigenlab.com verticalpharma.com **Revenue**: $337.4 Million Alora Pharmaceuticals, LLC is a parent company of si

Source

Indexed 1 year ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About morpheus

Morpheus is a recently emerged ransomware group first observed in January 2025, operating with apparent financial motivations and demonstrating a targeted approach to victim selection across multiple geographic regions. The group's origin and potential affiliations remain unclear due to limited public documentation from established threat intelligence sources, though their operational patterns suggest they may be operating independently rather than as part of a larger ransomware-as-a-service ecosystem. With 14 documented victims across diverse sectors including healthcare, business services, manufacturing, and hospitality, Morpheus has shown a preference for targeting organizations in the United States, Spain, India, Mexico, and Belgium, indicating either a broad operational reach or the use of automated targeting mechanisms that transcend geographic boundaries. The group's attack methodology, encryption techniques, and specific tactics, techniques, and procedures remain largely undocumented in public threat intelligence reporting from major cybersecurity firms and government agencies. Due to the group's recent emergence and limited public intelligence available from established sources such as CISA, FBI, or major threat intelligence providers, notable campaigns and high-profile incidents have not yet been extensively documented or analyzed in the public domain. Morpheus appears to remain active as of early 2025, though comprehensive assessment of their current operational status is limited by the nascent nature of their observed activities and the lack of extensive public reporting on their operations. The group has been linked to 21 public disclosures across our corpus. First observed on a leak site on January 7, 2025; most recent post July 6, 2026. The operation is currently active.

Timeline of this disclosure

April 1, 2025Alora Pharmaceuticals, LLC listed by morpheuson the group's public leak site

Ransom demanded: $337.4M

Other recent disclosures by morpheus

morpheus has been linked to 21 public victims on Darkfield. A sample of the most recent:

See the full morpheus dossier →

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,600 disclosures indexed across all operators we track. Geographically, Alora Pharmaceuticals, LLC is reported in United States, a country with 11,033 ransomware disclosures in our corpus.

If your organisation is affected

A listing by morpheus means Alora Pharmaceuticals, LLC appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
Report the incident to your national CERT, CISA (United States), as required for your jurisdiction.
Monitor for the data appearing on morpheus's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.